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Wnt signalling and its downstream effectors are well known for their roles in embryogenesis
and tumourigenesis, including the regulation of cell proliferation, survival and differentiation. In
the nervous system, Wnt signalling has been described mainly during embryonic development,
although accumulating evidence suggests that it also plays a major role in adult brain morpho-
genesis and function. Studies have predominantly concentrated on memory formation in the
hippocampus, although recent data indicate that Wnt signalling is also critical for neuroen-
docrine control of the developed hypothalamus, a brain centre that is key in energy balance reg-
ulation and whose dysfunction is implicated in metabolic disorders such as type 2 diabetes and
obesity. Based on scattered findings that report the presence of Wnt molecules in the tanycytes
and ependymal cells lining the third ventricle and arcuate nucleus neurones of the hypothala-
mus, their potential importance in key regions of food intake and body weight regulation has
been investigated in recent studies. The present review brings together current knowledge on
Wnt signalling in the hypothalamus of adult animals and discusses the evidence suggesting a
key role for members of the Wnt signalling family in glucose and energy balance regulation in
the hypothalamus in diet-induced and genetically obese (leptin deficient) mice. Aspects of Wnt
signalling in seasonal (photoperiod sensitive) rodents are also highlighted, given the recent evi-
dence indicating that the Wnt pathway in the hypothalamus is not only regulated by diet and
leptin, but also by photoperiod in seasonal animals, which is connected to natural adaptive
changes in food intake and body weight. Thus, Wnt signalling appears to be critical as a modu-
lator for normal functioning of the physiological state in the healthy adult brain, and is also
crucial for normal glucose and energy homeostasis where its dysregulation can lead to a range
of metabolic disorders.
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Introduction
In this review, we discuss the importance of Wnt signalling, which
has recently emerged as a key player in glucose and energy home-
ostasis in the hypothalamus of mammals, and we focus on various
aspects of hypothalamic Wnt signalling in obese and seasonal
models.
First discovered in Drosophila, the Wnt signalling pathway was
called ‘wingless’ (Wg) because its mutation led to a loss of wing
tissue (1). In mice, it was reported to promote tumour formation
and was termed ‘integration-1’ (int1) (2). Wingless and int1 were
later combined to ‘Wnt1’ because they are evolutionary highly
conserved and the large family of related genes is now commonly
known as Wnt (short for wingless-related integration site) genes,
part of the Wnt signalling pathway (3).
To date, 19 Wnt genes have been described that encode for pep-
tides and proteins acting in an autocrine/paracrine manner and
these often have overlapping or redundant functions (4). These
Wnts are involved in three different pathways, known as the
canonical b-catenin dependent signalling pathway and two non-
canonical b-catenin independent pathways leading to signal trans-
duction via c-jun N-terminal kinase (JNK) or Ca2+. Many Wnt
proteins, such as Wnt1, Wnt3a and Wnt10b, are involved in the
canonical b-catenin dependent pathway, resulting in b-catenin
activation, whereas only a few Wnt proteins (e.g. Wnt5a, Wnt11)
are involved in the two b-catenin independent pathways (Fig. 1).
The complex Wnt pathways have been reviewed extensively recently
(4–7) and we only provide a short summary here before discussing
aspects of Wnt signalling in the adult hypothalamus and energy
balance regulation.
A brief overview of the Wnt signalling pathways
The canonical b-catenin dependent pathway is well characterised
and is known for its involvement in the regulation of cell differenti-
ation and cell proliferation (4,5). The main biological effect is to
regulate b-catenin stabilisation by glycogen synthase kinase 3b
(GSK3b). Canonical Wnt/b-catenin signalling is activated when a
canonical Wnt ligand binds to a frizzled (Fzd) receptor, which then
forms a complex with the co-receptor lipoprotein receptor-related
protein (LRP) 5/6. This leads dishevelled (Dvl) to phosphorylate LRP,
thereby inactivating GSK3b. GSK3b inactivation in turn decreases
phosphorylation of the transcriptional co-activator b-catenin. Sta-
bilised cytoplasmatic b-catenin can then enter the nucleus where it
associates with transcription factors of the lymphoid enhancer fac-
tor (Lef)/T cell factor (TCF) family to regulate the transcription of
downstream target genes such as cyclin D1 and axin 2 (4–6). Addi-
tionally, several regulators of the Wnt pathway have been identi-
fied, some act by inhibiting the interaction of Wnt ligands with the
Fzd receptors, such as members of the secreted frizzle-related pro-
tein family (sFrp), and others interfere with the formation of an
active Fzd receptor-LRP complex, such as Dickkopf (Dkk) (7).
In the noncanonical pathways, Wnts function independently of
b-catenin. Similar to the b-catenin dependent pathway, Wnt
ligands bind to Fzd receptors forming a complex with a co-receptor.
This enables the planar cell polarity (PCP) pathway to activate JNK.
The downstream output of the PCP/JNK pathway regulates
cytoskeletal reorganisation and can lead to changes in cell polarity
by directing Dvl signals to the monometric GTPases Rho and Rac,
which stimulate Rho-associated protein kinase and JNK, respectively
(4). The second b-catenin independent pathway, which was first
described in zebrafish (Danio rerio) and Xenopus laevis embryos, is
the Wnt/Ca2+ pathway (8). Here, Wnts trigger Fzd-mediated activa-
tion of G-protein, which in turn up-regulates phospholipase C to
increase intracellular Ca2+ and diacylglycerol. This stimulates protein
kinase C and the rise in intracellular Ca2+ that enables CamKII and
calcineurin to modulate transcription through the regulation of
cAMP response element-binding protein and nuclear factor of acti-
vated T cells. The Wnt/Ca2+ pathway is prominently involved in can-
cer, inflammation and neurodegeneration (4).
The three Wnt pathways do not function autonomously; rather,
they can act in concert with many Wnt ligands and their down-
stream targets are often involved in more than one pathway, which
often regulate each another (6) (Fig. 1).
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Fig. 1. Overview of the Wnt signalling pathways. Wnt signalling occurs as (A) the canonical, (B) planar cell polarity (PCP) and (C) Wnt/Ca2+ pathways. APC,
adenomatous polyposis coli; Axin, Axis-inhibition protein; CAMK2, calcium/calmodulin-dependent protein kinase II; CK1, casein kinase 1; DAAM, dishevelled-
associated activator of morphogenesis; GSK3, glycogen synthase kinase 3; JNK, c-Jun N-terminal kinase; NFAT, nuclear factor of activated T cells; PKC, protein
kinase C; ROCK, Rho-associated protein kinase; TCF7, Transcription factor 7.
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Evidence for Wnt signalling in the developed
hypothalamus
Wnt proteins have been considered as important mediators of cell–
cell communication and play a prominent role in diverse cellular pro-
cesses ranging from cardiovascular physiology to cancer metabolism
(3,9). In the nervous system, the Wnt pathway has been predomi-
nantly characterised in embryonic development. Within the past dec-
ade, it became clear that it also plays a major role in the adult brain
morphogenesis and function. To date, Wnt signalling has only been
described in a limited number of brain regions and brain functions,
with studies mainly focussing on the hippocampus. The hippocam-
pus is important for learning and memory, and a rich literature now
links the family of Wnt genes with hippocampal plasticity and mem-
ory formation (5). Recent data indicate that Wnt signalling also
requires investigation in the hypothalamus, the brain centre that is
key in energy balance regulation (10). Here, Wnt signalling was ini-
tially also studied in the context of early neural development where
its importance was shown in vitro in hypothalamic neuropeptide Y
(NPY) cell lines and in vivo in mouse and zebrafish hypothalamic
development (11–15). Using Lef1 loss-of-function zebrafish embryos,
Lee et al. (11) were able to demonstrate that the transcriptional acti-
vator Lef1 is essential during the development of the posterior
hypothalamus in zebrafish, and also that it signals through the
canonical Wnt pathway in this brain region. Subsequently, it was
demonstrated that Wnt signalling in the hypothalamus is required
for the differentiation of neural progenitors during the entire
lifespan in zebrafish (16,17) and this is evolutionary conserved
throughout the vertebrate subphylum because Wnt signalling is also
essential in the hypothalamus of mice, where it acts as an inhibitor
of radial glia differentiation (17). These data suggested that Wnt
signalling required a more careful consideration in the adult
hypothalamus.
One of the first indications that Wnt signalling is important in
the developed mammalian hypothalamus emerged from microarray
studies conducted in seasonal mammals, which identified differen-
tial gene regulation of components of the Wnt pathway in
response to photoperiod (day length) in key regions of energy
balance regulation (18). At the same time, the mediobasal
hypothalamus of adult mice was found to contain a Wnt-respon-
sive cell population (17) and reports in diet-induced and geneti-
cally obese (leptin deficient) mice indicated a critical role for
hypothalamic Wnt signalling in the energy and glucose metabo-
lism of mammals (19,20). Key loci for Wnt signalling within the
hypothalamus are the tanycytes and ependymal cells lining the
third ventricle and the arcuate nucleus neurones, which comprise
an important centre of body weight regulation because these cells
express all of the Wnt signalling genes (i.e. from ligands to target
genes) (17,20,21) (Fig. 2). Recent work from divergent fields has
emphasised the importance of tanycytes and ependymal cells in
neuroendocrine function. From an appetite and energy balance
perspective, it has become evident that they represent a stem cell
population that gives rise to the appetite regulatory neurones
essential for metabolic regulation, whereas research in seasonal
biology has shown that these cells are crucial for long-term
changes in metabolic physiology (22).
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Fig. 2. The neuroanatomical location of Wnt signalling genes in the hypothalamus. (A) Overview of a rat brain. The dotted lines indicate the position of the
coronal section in (B). (B) Diagram of a rat brain, detailing the hypothalamic region that expresses Wnt signalling genes. All of the Wnt genes that have been
investigated so far are expressed in the ependymal layer lining the third ventricle and the arcuate nuclei. (C) Wnt signalling genes are expressed in the brain
of F344 rats, including the cortex, hippocampus and hypothalamus. The coronal sections show the expression of the antagonist Dickkopf 3 (Dkk3) in the
ependymal layer as a representative example for many Wnt molecules. Dkk3 mRNA was detected by in situ hybridisation with antisense 35S-labelled riboprobes
in F344 rats held under long photoperiod or a short photoperiod for 4 weeks. Magnifications show a detailed view of the hypothalamic regions indicated in
(B). ARC, arcuate nucleus; ME, median eminence, 3V, third ventricle.
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The neuroendocrine role of Wnt signalling in glucose
and energy homeostasis
Recent work has highlighted a critical role for Wnt signalling in the
neuroendocrine control of glucose and energy metabolism of mam-
mals, where its dysregulation has been profoundly implicated in
metabolic disorders such as type 2 diabetes and obesity. An initial,
striking link between Wnt signalling and metabolic impairments
was established by genome-wide association studies in humans
that linked the transcriptional co-activator of b-catenin, TCF7/L2,
with a higher risk of developing type 2 diabetes (23–25). Further
indications linking the Wnt signalling system with glucose home-
ostasis were provided by in vitro studies showing that the Wnt/b-
catenin pathway is responsive to glucose (26). In addition, GSK3b,
an endogenous inhibitor of the canonical Wnt signalling pathway,
potently affects energy and glucose homeostasis in a diet-sensitive
manner (19).
Because, within the brain, it is the hypothalamus that is critical
in sensing and integrating peripheral signals (10), Wnt signalling
molecules were investigated in hypothalamic regions that play a
role in metabolic homeostasis (19,20). Although the expression of
Wnt signalling genes was found throughout the brain, not surpris-
ingly including the hippocampus (5), most genes were also strongly
expressed in the mediobasal hypothalamus containing the arcuate
nucleus, the appetite-regulating centre (20) (Fig. 2 and Table 1). It
is well established that the arcuate nucleus contains cell popula-
tions that are leptin-responsive, with leptin inhibiting orexigenic
Agouti-related peptide/NPY neurones and activating anorexigenic
pro-opiomelanocortin (POMC) neurones (10). In leptin-deficient
mice, Wnt signalling was impaired in the mediobasal hypothalamus.
The expression of Wnt ligands, Wnt7a and Wnt4, as well as the
Wnt target genes, axin-2 and cyclin D1, was lower in Lepob/ob mice
compared to Lep+/+ mice (Table 1). This effect was dependent on
the lack of leptin because leptin replacement restored gene expression.
Table 1. Summary of Hypothalamic Wnt Signalling Genes in Different Model Organisms and the Known Stimuli That Cause Gene Expression Changes.
Functional gene grouping Gene name Species
Stimulus for gene
expression change
if known Reference
Wnt/b-catenin pathway
Axin-1 Axin-1 Mouse 20
TCF-7 T-cell specific transcription factor 7 Mouse 20
b-Cat b-catenin Mouse 20
DSL Dishevelled Mouse 20
Rat LP↑ 44
Fzd5 Frizzled homologue 5 Mouse 20
GSK-3b Glycogen synthase Mouse Leptin↑ HFD↑ 19,20
kinase 3b Hamster 27
Lef 1 Lymphoid enhancer binding factor 1 Rat LP↑ 44
Fzd9 Frizzled homologue 9 Rat LP↑ 44
Tcf-3 Transcription factor 3 Rat LP↑ 44
Wnt/Ca2+ pathway/ligands
Wnt4 Wingless-type 4 Mouse Leptin↑ 20
Hamster LP↑ 27
Wnt7a Wingless-type 7a Mouse Leptin↑ 20
Wnt9a Wingless-type 9a Rat LP↑ 44
Wnt9b Wingless-type 9b Rat LP↑ 44
Wnt signalling regulation
Dkk1 Dickkopf 1 Mouse Leptin↑ 19
Dkk3 Dickkopf 3 Mouse 20
Rat LP↑ NMU↑ 21,44
Hamster 27
sFrp2 Secreted frizzle related protein 2 Rat LP↑ NMU↑ 21,44,45
Hamster LP↑ 27
Mfrp Membrane frizzle related protein Rat LP↑ 45
Wnt-signalling target genes
Axin-2 Axis inhibition protein 2 Mouse Leptin↑ 20
Hamster 27
CCND1 Cyclin D1 Mouse Leptin↑ 20
Hamster 27
HFD, high-fat diet; LP, long photoperiod; NMU, neuromedin U.
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Furthermore, pharmacological blockade of Wnt/b-catenin signalling
with the endogenous Wnt inhibitor Dkk1 prevented the ability of
leptin to improve glucose homeostasis (19,20). Leptin activates Wnt
signalling via GSK3b inhibition in leptin responsive NPY neurones,
suggesting that the catabolic action of the hormone is mediated via
hypothalamic WNT signalling (19,20). The idea that the Wnt pathway
represents a novel integration site for the leptin signal is further
confirmed by recent finding that leptin administration acutely leads
to the activation of LRP-6 in hamsters and mice (20,27). Additional
studies are required to clarify whether leptin directly activates the
Wnt co-receptor (e.g. through interaction with leptin receptor associ-
ated Janus kinase) or whether the activation is indirect and distal to
the leptin receptor. The very rapid activation of LRP-6 (within 15 min
after i.p. leptin administration) points toward a direct action of leptin
on the Wnt pathway (Fig. 3).
In line with this evidence, targeted deletion of b-catenin in the
hypothalamus of mice also had direct effects on NPY and POMC
neurones, leading to a reduction in postnatal body weight com-
pared to control mice (28), which suggests that the Wnt pathway
regulates obesity by controlling food intake behaviour. In this con-
text, it is also interesting to note that challenges to metabolic
homeostasis via energy restriction alter the expression of genes
associated with Wnt signalling in the mouse hypothalamus in an
age-dependant manner (29).
Wnt pathway in whole body metabolism
In addition to the neuroendocrine role of Wnt signalling in centrally
controlled energy balance regulation, recent evidence suggests that
Wnt/b-catenin signalling also regulates whole-body metabolism,
acting on peripheral organs and tissues involved in systemic energy
homeostasis. For example, inactivation of b-catenin in the murine
liver has been implicated in the development of diet-induced fatty
liver disease, obesity and systemic insulin resistance (30). In the
pancreas of adult mice, targeted deletion of b-catenin leads to glu-
cose intolerance and protection from diet-induced obesity and insu-
lin resistance (31).
It is now well recognised that adipose tissue is crucial for the
regulation of energy homeostasis (32). A number of studies have
suggested that components of the Wnt/b-catenin pathway play an
important role in adipocyte function and adipogenesis by inhibiting
the differentiation of adipose tissue progenitor cells (33–36) and
this has been implicated in the control of adipose tissue with
respect to the regulation of glucose homeostasis and the develop-
ment of obesity (37–40). The importance of Wnt activation in adi-
pogenesis has mainly been supported by data obtained in vitro,
although it has also been confirmed by an in vivo study showing
that adipocyte-specific over-expression of Wnt10b in Lepob/ob mice
stabilises b-catenin, thereby reducing adiposity and improving insu-
lin sensitivity (35,36).
All of these studies have focused on the b-catenin dependent
Wnt pathway in adipose tissue biology and energy homeostasis. A
very recent study has shown that the noncanonical Wnt pathways
also play an essential role in obesity and metabolic dysfunction by
increasing adipose tissue inflammation. Fuster et al. (41) showed
that over-expression of Wnt5a, a Wnt protein associated with the
noncanonical pathway (42), increases adipose tissue inflammation,
leading to a greater impairment of glucose homeostasis. Conversely,
Wnt5a ablation in diet-induced obese mice reduces adipose tissue
inflammation and thereby insulin resistance. The effects of Wnt5a
are independent of adipogenesis or adipose tissue expansion (41).
Interestingly, changes in adipose Wnt signalling can precede adi-
posity, as demonstrated in an elegant study investigating the epige-
netic mechanisms involved in obesity (43). Wnt signalling genes
regulate adipose tissue expansion in mice with low and high weight
gain and this can even occur before mice are fed a high-fat diet. In
addition to the effect of Wnt signalling genes on adipose tissue,
gene expression was also compared in the brain of low and high
weight gaining mice, although differences in Wnt molecules in the
hypothalamus were not detected (43).
Wnt signalling in seasonal animals
Together, these data provide persuasive evidence for a significant role
of Wnt signalling in glucose homeostasis and energy balance regula-
tion in abnormal physiological states. It is clear that aberrant Wnt
signalling can lead to a range of metabolic disorders. Much less com-
mon are reports of the Wnt signalling pathway as a modulator of the
physiological state in the healthy adult brain. Yet, recent evidence has
shown that the Wnt signalling pathway in the hypothalamus is regu-
lated not only by diet and leptin, but also by photoperiod (day length)
in seasonal mammals (18,21,44,45), which is connected to natural
adaptive changes in body weight and food intake (46). Mammalian
species sensitive to photoperiod changes, such as the Djungarian
(Siberian) hamster (Phodopus sungorus), the common vole (Microtus
arvalis), the F344 rat strain and the CBA/N mouse strain, are impor-
tant animal models for studying long-term physiological changes in
energy balance, in which a simple change in the environmental pho-
toperiod cue induces dramatic and robust alterations in food intake,
body weight and body composition. In the examples noted above,
short (winter-like) photoperiods lead to a decrease in food intake and
body weight, whereas, in long (summer-like) photoperiods, food
intake and body weight are increased.
Although laboratory rats are generally not responsive to pho-
toperiod, the juvenile F344/NHsd rat is one of the few strains of
rats that has retained its photoperiodic sensitivity in terms of
reproductive function, growth and metabolism (45,47), therefore
providing a useful system for dissecting pathways that regulate
photoperiodic gene expression in the hypothalamus. Genome-wide
expression analyses comparing these two natural states in the
photoperiod-sensitive F344 rat indicate that, in addition to the
well-characterised photoperiod induced changes in thyroid hormone
signalling gene expression (48), the Wnt/b-catenin signalling
pathway is another major pathway altered in response to photope-
riod (18). Subsequently, a whole range of Wnt related genes are
described as being up-regulated by a long photoperiod and these
are predominantly members of the canonical Wnt/b-catenin path-
way (21,44,45) (Table 1). These changes, however, are independent
of changes in local hypothalamic thyroid hormone signalling, a
potent driver of seasonal body weight regulation, because central
© 2016 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd
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Fig. 3. Model of Wnt signalling in energy balance regulation. (A) Leptin activates lipoprotein receptor-related protein (LRP)-6, which results in inactivation of
glycogen synthase kinase 3b (GSK3b). This might trigger a positive-feedback loop in which the phosphorylation by GSK3b on inhibitory phosphorylation sites
of insulin receptor substrate 1 (IRS-1) is reduced. The modification of IRS-1 might result in an activation of the IRS-phosphoinositide 3-kinase (PI3K) pathway
by insulin increasing phospho-AKT. Phospho-AKT then might enhance this mechanism through inactivation of GSK3b. (B) By contrast, in genetically obese lep-
tin-deficient mice, there is no inactivation of LRP-6 by leptin. Therefore, increased GSK-3b activity inhibits IRS-1 through phosphorylation of inhibitory sites.
This inhibition can potentially lead to hypothalamic insulin resistance and subsequently to the development of type-2 diabetes. Axin-2, Axin inhibition protein
2; DKK1, Dickkopf 1; LepR, leptin receptor; IR, insulin receptor; JAK, Janus kinase. Reprinted with permission (20).
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administration of thyroid-stimulating hormone does not alter the
expression of Wnt-signalling genes in the ependymal layer of F344
rats (44). This is interesting given that most seasonal research
focuses on the importance of thyroid hormone driving seasonal
energy balance regulation, emphasising that other pathways might
play an equally important role in this process (48).
In the F344 rat, the Wnt signalling genes are predominantly
expressed in the ependymal cells and tanycytes lining the third
ventricle of the hypothalamus (21) (Fig. 2). A similar photoperiodic
response of Wnt pathway molecules has been confirmed in the
hypothalamus of Djungarian (Siberian) hamster, although here
abundant expression occurs for most genes in the arcuate nucleus
(27). In addition to a species-specific expression pattern, the
anatomical location for individual Wnt genes also appears to be
heterogeneous. For example, in the hamster, Wnt7a is expressed in
the lateral part of the arcuate nucleus towards the border of the
lateral hypothalamus, whereas Dkk3 is mainly expressed medially in
the tanycytes (27). The observation that the Wnt components are
not expressed uniformly in hypothalamic nuclei suggests that
individual components of the system might play different roles in
different locations.
In conjunction with the findings described in obese models, it is
reasonable to speculate that the photoperiod-induced changes in the
Wnt pathway are also directly related to changes in glucose and
energy homeostasis. Some support for this hypothesis may be evi-
dent from the finding that neuromedin U (NMU), a neuropeptide
that has been linked to acute energy balance regulation (49),
increases mRNA expression of two regulators of the canonical Wnt
pathway, sFrp2 and Dkk3, in the ependymal layer of F344 rats (44).
However, intracerebral injections of NMU rapidly decreased food
intake and body weight and increased energy expenditure and ther-
mogenesis in seasonal and obese model systems (44,49–52). These
rapid changes associated with acute energy balance regulation do
not comply with the long-term changes in seasonal animals, where
long photoperiod, which is associated with an increase in food intake
and body weight, increases Wnt signalling pathway genes (Table 1).
A hypothesis more consistent with the longer-term physiological
changes characteristic of seasonal animals would be that seasonal
changes in Wnt signalling gene expression might contribute to the
cellular and structural remodelling of the hypothalamic networks
involved in the control of seasonal energy balance. Studies con-
ducted in the hamster and sheep suggest that morphological
changes in the mediobasal hypothalamus are associated with
changes in photoperiod (53–56). In the F344 rat, cell proliferation
in the hypothalamus is also under seasonal control (57), suggesting
that some form of structural and cellular re-modelling may be part
of the neuroendocrine mechanism involved in the seasonal regula-
tion of energy balance.
As described earlier, the Wnt pathway has been strongly impli-
cated in synaptic maintenance and function, as well as adult neu-
rogenesis. Importantly, hypothalamic neurogenesis appears to be
significant in the regulation of multiple neuroendocrine pathways,
such as in the control of feeding behaviour and body weight
regulation (58–61). Consistent with this idea, Wnt signalling regu-
lates hypothalamic progenitor differentiation in the zebrafish (17).
Tanycytes are essential for neuroendocrine function in the hypotha-
lamus, and these radial glial cells also serve as a neural progenitor
population (22). It is primarily the tanycytes that express the Wnt
signalling genes in the F344 rat in a photoperiodic manner. Inter-
estingly, the tanycytes also express retinoic acid signalling compo-
nents (21,57,62) and, in the hippocampus of the adult mouse
where adult neurogenesis has been confirmed, members of the Wnt
gene family are downstream components of retinoic acid-regulated
neurogenesis (63). Furthermore, the G protein coupled receptor 50
(GPR50), a melatonin-related receptor, appears to promote neuronal
differentiation of embryonic neuronal progenitor cells through
canonical Wnt signalling (64). This is significant because GPR50 is
expressed in tanycytes (65) adjacent to or overlapping with Wnt
signalling genes (20,21) and knockout of GPR50 in mice is func-
tionally linked to energy homeostasis leading to an aberrant leptin
response (66,67).
However, in contrast to this hypothesis, Wang et al. (17) found
that Wnt pathway activation leads to a decrease of tanycyte num-
bers in the mouse hypothalamus, suggesting that tanycyte forma-
tion and maintenance does not necessarily require Wnt signalling
in mammals, thus adding yet another level of complexity. Therefore,
the biological role of Wnt signalling and its potential role in
hypothalamic neurogenesis in seasonal mammals remains a fascinating
avenue for further research.
Concluding remarks
Collectively, several studies conducted in seasonal and obese mod-
els have revealed a specific role for members of the Wnt signalling
family in energy balance regulation. Based on scattered findings
that report the presence of Wnt molecules in the hypothalamus
and indicate their potential importance in key regions of food
intake and body weight regulation (17,18), work undertaken in our
laboratories has begun to follow up the individual Wnt genes
involved in this system and decipher their relevance. It is clear that
hypothalamic Wnt signalling is a critical signalling pathway utilised
by leptin, and appears to be a key mechanism providing conver-
gence in the actions of leptin and insulin (19,20). However, research
on this topic is still in its infancy, and considerably more work is
required to clarify the molecular mechanisms involved and its pre-
cise biological significance.
Nevertheless, these findings have now opened the field to future
studies investigating the central role of this process in the neuronal
control of metabolism. The hypothalamus of seasonal mammals
comprises a strong model for studying Wnt function in the healthy
brain, whereas targeting Wnt signalling pathways in diet-induced
and genetically obese models can potentially lead to therapeutic
benefits for metabolic disorders such as diabetes and obesity in
humans.
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